Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Non-randomized non-controlled open trial 		Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Mesenchymal stem cells
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
EXO-CD24
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Experimental Other treatment Jul/13/2022
BNT162b2
Non-randomized non-controlled open trial 		Approved by FDA Experimental Vaccine Jun/22/2022
Anakinra 
Non-randomized non-controlled open trial 		Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Tocilizumab
Non-randomized non-controlled open trial 		Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Hydroxychloroquine sulfate
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
Itolizumab
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/29/2021
Azithromycin
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021
INO-4800
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Experimental Vaccine Dec/23/2020
rAd5-S
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
rAd26-S
Non-randomized non-controlled open trial 		Potential treatment - clinical evidence Experimental Vaccine Sep/04/2020
Export (.csv)